| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 1. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | vinorelbine (Navelbine®) |
| Formulation | 10 mg/ml concentrate for solution for infusion |
| Reference number | 331 |
| Indication | As a single agent or in combination for the first line treatment of stage III or IV non small cell lung cancer |
| Company | Pierre Fabre Ltd |
| BNF chapter | Malignant disease & immunosuppression |
| Assessment type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 22/11/2004 |